Page 1 | Search Results | Blood | American Society of Hematology

1-9 of 9

Sort by

Sort Order Select

Journal Articles

Meta-Analysis of Long-Term Risk of Recurrent Venous Thromboembolism after Stopping Anticoagulation in Men and Women with First Unprovoked Venous Thromboembolism

Blood (2018) 132 (Supplement 1): 2527.

https://doi.org/10.1182/blood-2018-99-113589

Published: 2018

Journal Articles

Healthcare Cost Impact of Continued Anticoagulation Therapy with Rivaroxaban Versus Aspirin for Prevention of Recurrent Symptomatic Venous Thromboembolism in the Einstein Choice Trial Population

Bruce L. Davidson, MD MPH, Philip S. Wells, MD FRCPC, MSc, Martin H. Prins, MD PhD, Jan Beyer-Westendorf, MD, Anthonie WA. Lensing, MD PhD, Lloyd Haskell, MD, Bennett Levitan, MD PhD, François Laliberté, Veronica Ashton, MPH, Yongling Xiao, PhD, Dominique Lejeune, Concetta Crivera, Patrick Lefebvre, MA, Qi Zhao, MPH, Zhong Yuan, MD PhD, Jeff Schein, Paolo Prandoni, MD PhD

Blood (2017) 130 (Supplement 1): 218.

https://doi.org/10.1182/blood.V130.Suppl_1.218.218

Published: 2017

Journal Articles

Performance Of The Simplified Pesi Score In Patients With Pulmonary Embolism Treated With Rivaroxaban Or Standard Therapy

Petra MG Erkens, PhD, Gregory J Fermann, MD, FACEP, Martin H Prins, MD, Philip S Wells, MD, MSc, Akos F Pap, MSc, Anthonie WA Lensing, MD

Blood (2013) 122 (21): 1139.

https://doi.org/10.1182/blood.V122.21.1139.1139

Published: 2013

Journal Articles

Safety of Outpatient Treatment In Acute Pulmonary Embolism.

Petra MG Erkens, MSc, Esteban Gandara, MD, Phil Wells, MD, MSc, Alex Yi-Hao Shen, BSc, Gauruv Bose, Gregoire Le Gal, MD, PhD, Marc A. Rodger, MD, FRCPC, Martin H Prins, MD, PhD, Marc Carrier, MD, MSc

Blood (2010) 116 (21): 3796.

https://doi.org/10.1182/blood.V116.21.3796.3796

Published: 2010

Journal Articles

Idrabiotaparinux, a Biotinylated Long-Acting Anticoagulant, in the Treatment of Deep Venous Thrombosis (EQUINOX Study): Safety, Efficacy, and Reversibility by Avidin

Harry Roger Buller, MD, PhD, Jean-Michel Destors, Alexander S. Gallus, MD, Martin H Prins, MD, PhD, Gary Edward Raskob, PhD

Blood (2008) 112 (11): 32.

https://doi.org/10.1182/blood.V112.11.32.32

Published: 2008

Journal Articles

Once Daily YM150, an Oral Direct Factor Xa Inhibitor, for Prevention of Venous Thromboembolism in Patients Undergoing Elective Primary Hip Replacement.

Bengt I. Eriksson, MD, PhD, Alexander G.G. Turpie, MD, PhD, Michael R. Lassen, MD, PhD, Martin H. Prins, MD, PhD, Giancarlo Agnelli, MD, PhD, Peter Kälebo, MD, PhD, Graham Wetherill, MSc, Lambertus Meems, MSc.

Blood (2007) 110 (11): 309.

https://doi.org/10.1182/blood.V110.11.309.309

Published: 2007

Journal Articles

No Difference in Risk of Recurrent Venous Thrombosis between Men and Women. Results from a Family Cohort Study in 3356 Subjects.

Willem M. Lijfering, MD, Michiel Coppens, MD, Nic J.G.M. Veeger, MSc, Saskia Middeldorp, MD, PhD, Karly Hamulyak, MD, PhD, Martin H. Prins, MD, Phd, Harry R. Buller, MD, PhD, Jan van der Meer, Md, PhD

Blood (2007) 110 (11): 130.

https://doi.org/10.1182/blood.V110.11.130.130

Published: 2007

Journal Articles

Prevalence and Characteristics of Occult Cancer in Patients with Venous Thromboembolism.

Marielle M.J. Beckers, MD, Roger E.G. Schutgens, MD, PhD, Martin H. Prins, MD, PhD, Douwe H. Biesma, MD, PhD

Blood (2005) 106 (11): 1623.

https://doi.org/10.1182/blood.V106.11.1623.1623

Published: 2005

Journal Articles

YM150, an Oral Direct Factor Xa Inhibitor, as Prophylaxis for Venous Thromboembolism in Patients with Elective Primary Hip Replacement Surgery. A Dose Escalation Study.

Bengt I. Eriksson, MD, Alexander G.G. Turpie, MD, Michael R. Lassen, MD, Martin H. Prins, MD, Giancarlo Agnelli, MD, Marleen L. Gaillard, PhD, Bert Meems, MSc

Blood (2005) 106 (11): 1865.

https://doi.org/10.1182/blood.V106.11.1865.1865

Published: 2005

NARROW

Meta-Analysis of Long-Term Risk of Recurrent Venous Thromboembolism after Stopping Anticoagulation in Men and Women with First Unprovoked Venous Thromboembolism

Healthcare Cost Impact of Continued Anticoagulation Therapy with Rivaroxaban Versus Aspirin for Prevention of Recurrent Symptomatic Venous Thromboembolism in the Einstein Choice Trial Population

Performance Of The Simplified Pesi Score In Patients With Pulmonary Embolism Treated With Rivaroxaban Or Standard Therapy

Safety of Outpatient Treatment In Acute Pulmonary Embolism.

Idrabiotaparinux, a Biotinylated Long-Acting Anticoagulant, in the Treatment of Deep Venous Thrombosis (EQUINOX Study): Safety, Efficacy, and Reversibility by Avidin

Once Daily YM150, an Oral Direct Factor Xa Inhibitor, for Prevention of Venous Thromboembolism in Patients Undergoing Elective Primary Hip Replacement.

No Difference in Risk of Recurrent Venous Thrombosis between Men and Women. Results from a Family Cohort Study in 3356 Subjects.

Prevalence and Characteristics of Occult Cancer in Patients with Venous Thromboembolism.

YM150, an Oral Direct Factor Xa Inhibitor, as Prophylaxis for Venous Thromboembolism in Patients with Elective Primary Hip Replacement Surgery. A Dose Escalation Study.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only